MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-18-2026
Charles River Laboratories International Total Inventories 2011-2026 | CRL
Annual Total Inventories Charles River Laboratories International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 299 M | 279 M | 380 M | 256 M | 199 M | 186 M | 161 M | 128 M | 115 M | 95.8 M | 93.7 M | 89 M | 89.4 M | 88.5 M | 93 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 380 M | 88.5 M | 170 M |
Quarterly Total Inventories Charles River Laboratories International
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 303 M | 280 M | 290 M | 279 M | 336 M | 349 M | - | 380 M | 293 M | 285 M | 263 M | 256 M | 262 M | - | 221 M | 199 M | 182 M | 194 M | 194 M | 186 M | 186 M | 186 M | 186 M | 161 M | 161 M | 161 M | 161 M | 128 M | 128 M | 128 M | 128 M | 115 M | 115 M | 115 M | 115 M | 95.8 M | 95.8 M | 95.8 M | 95.8 M | 93.7 M | 93.7 M | 93.7 M | 93.7 M | 89 M | 89 M | 89 M | 89 M | 89.4 M | 89.4 M | 89.4 M | 89.4 M | 88.5 M | 88.5 M | 88.5 M | 88.5 M | 93 M | 93 M | 93 M | 93 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 380 M | 88.5 M | 160 M |
Total Inventories of other stocks in the Diagnostics research industry
| Issuer | Total Inventories | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Agilent Technologies
A
|
830 M | $ 115.6 | 0.06 % | $ 35.1 B |  USA |
 |
Accelerate Diagnostics
AXDX
|
5.19 M | - | -61.36 % | $ 2.46 M | USA |
 |
Co-Diagnostics
CODX
|
992 K | $ 1.65 | -1.2 % | $ 2.19 M | USA |
 |
Aspira Women's Health
AWH
|
256 K | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
757 K | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
8.14 M | $ 24.8 | 1.39 % | $ 689 M | USA |
 |
Chembio Diagnostics
CEMI
|
7.72 M | - | 0.22 % | $ 16.8 M | USA |
 |
CareDx, Inc
CDNA
|
26.7 M | $ 21.22 | -0.05 % | $ 1.13 B | USA |
 |
Illumina
ILMN
|
547 M | $ 127.82 | -0.05 % | $ 20.3 B | USA |
 |
DermTech
DMTK
|
1 M | - | -11.32 % | $ 2.94 M | USA |
 |
Enzo Biochem
ENZ
|
6.83 M | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
166 M | - | - | $ 19.8 B | USA |
 |
Global Cord Blood Corporation
CO
|
45.9 M | - | - | $ 399 M |  China |
 |
Lantheus Holdings
LNTH
|
64.7 M | $ 84.53 | 0.24 % | $ 5.7 B | USA |
 |
Guardant Health
GH
|
85.9 M | $ 89.33 | 0.47 % | $ 11.2 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
909 K | - | -20.0 % | $ 1.06 M | USA |
 |
Heska Corporation
HSKA
|
60 M | - | - | $ 1.31 B | USA |
 |
Interpace Biosciences
IDXG
|
1.11 M | $ 1.93 | -2.08 % | $ 8.54 M | USA |
 |
Senseonics Holdings
SENS
|
6.7 M | $ 7.17 | 1.7 % | $ 299 M | USA |
 |
Motus GI Holdings
MOTS
|
496 K | - | -34.28 % | $ 263 K |  Israel |
 |
Soleno Therapeutics
SLNO
|
15 M | $ 52.75 | 0.05 % | $ 2.68 B | USA |
 |
QIAGEN N.V.
QGEN
|
302 M | - | - | $ 10.6 B |  Niderland |
 |
Neogen Corporation
NEOG
|
191 M | $ 9.51 | -0.37 % | $ 2.06 B | USA |
 |
Biomerica
BMRA
|
1.49 M | $ 2.15 | 0.7 % | $ 4.94 M | USA |
 |
Thermo Fisher Scientific
TMO
|
5.42 B | $ 467.93 | -0.35 % | $ 176 B | USA |
 |
ICON Public Limited Company
ICLR
|
2.3 M | $ 101.57 | -0.59 % | $ 8.38 B |  Irlanda |
 |
Laboratory Corporation of America Holdings
LH
|
535 M | $ 263.9 | 0.06 % | $ 22 B | USA |
 |
Twist Bioscience Corporation
TWST
|
28.3 M | $ 60.76 | -0.3 % | $ 3.63 B | USA |
 |
OpGen
OPGN
|
3.65 M | - | -16.95 % | $ 1.54 M | USA |
 |
NeoGenomics
NEO
|
28.6 M | $ 8.57 | 3.44 % | $ 1.1 B | USA |
 |
Myriad Genetics
MYGN
|
30.6 M | $ 4.76 | -0.42 % | $ 441 M | USA |
 |
Natera
NTRA
|
35.4 M | $ 204.88 | 0.55 % | $ 20.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
189 M | $ 196.9 | 0.35 % | $ 21.9 B | USA |
 |
Invitae Corporation
NVTA
|
30.4 M | - | - | $ 21.2 M | USA |
 |
PerkinElmer
PKI
|
379 M | - | -0.91 % | $ 14.7 B | USA |